North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 785 Jul 28 – Oct 25, 2026
- Disclosed funding
- $110B 630 disclosed amounts
- Median round
- $24.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VH Verily HealthCompany profile An AI-native precision-health platform organizes complex health data for research, care and personalized health services. An AI-native precision-health platform organizes complex health data for research, care and personalized health services. | Undisclosed | March financing extensionUndisclosed | Healthtech | United States | Investors | |
| M Moneyball.aiCompany profile AI deal-team software helps boutique investment banks match deals to investors and manage outreach through closing. AI deal-team software helps boutique investment banks match deals to investors and manage outreach through closing. | Undisclosed | Pre-seed | Fintech | United States | Investors | |
| C CelligenceCompany profile Celligence develops AngelAi, a conversational financial platform centered on mortgage origination and servicing. Borrowers and lenders can use its AI assistant to move from application intake and document review through loan analysis and approval, while financial institutions can integrate the platform into lending operations. Celligence develops AngelAi, a conversational financial platform centered on mortgage origination and servicing. Borrowers and lenders can use its AI assistant to move from application intake and document review through loan analysis and approval, while financial institutions can integrate the platform into lending operations. | ≤$100M | Strategic investmentUndisclosed | Fintech | Puerto Rico | Investors | |
| V VideoGenCompany profile AI video-creation software that helps creators, businesses and teams turn briefs or source media into editable, localized videos. AI video-creation software that helps creators, businesses and teams turn briefs or source media into editable, localized videos. | $3.3M | Seed | AI | United States | Investors | |
LatitudeCompany profile Provides payment infrastructure connecting stablecoins with local currencies and payment networks. Provides payment infrastructure connecting stablecoins with local currencies and payment networks. | $35M | Series A | Fintech | United States | Investors | |
| SO Solstice OncologyCompany profile A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment. A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment. | $225M | Series A | Biotech | United States | Investors | |
| CC Celero CommunicationsCompany profile Celero develops coherent digital signal processors and analog technology for optical links that connect AI accelerators and data centers. Its validated 2nm silicon architecture is designed to move more data across scale-up, scale-out and data-center links with lower power and a path from 1.6T to next-generation 3.2T connectivity. Celero develops coherent digital signal processors and analog technology for optical links that connect AI accelerators and data centers. Its validated 2nm silicon architecture is designed to move more data across scale-up, scale-out and data-center links with lower power and a path from 1.6T to next-generation 3.2T connectivity. | $275M | Series CSeries C+ | Hardware | United States | Investors | |
| L LightsageCompany profile An agent-led growth platform measures whether AI agents can discover, evaluate and successfully use a company’s software. An agent-led growth platform measures whether AI agents can discover, evaluate and successfully use a company’s software. | $4M | FundingUndisclosed | AI | United States | Investors | |
| CI ClaimQI, Inc.Company profile Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language. Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language. | ~$500K | Seed | Healthtech | United States | Investors | |
| ET Encoded Therapeutics Inc.Company profile Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome. Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome. | $275M | Series FSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 28, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Databuddy Analytics
59rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
42rounds16led - 3Khosla Ventures
Arda Industries, Tolan
26rounds6led - 4Sequoia Capital
Warhound, Whop, Blacksmith
23rounds7led - 5Alumni Ventures
Maxinsights, Daytona, Chariot Claims
22rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.